Cheaper, faster method produces 10x more
Manufacturing the groundbreaking and extremely popular diabetes and weight-loss drug semaglutide – Ozempic, Wegovy – is a complex, slow process. Amid ongoing global shortages, researchers have developed a cheaper, faster method that produces ten times more of a therapeutically similar version of the in-demand drug.The effectiveness of semaglutide, sold as the diabetes drug Ozempic and weight-loss drug Wegovy, contributed to its overwhelming popularity and huge demand. This led to global shortages throughout 2022–23, which…